ABCL icon

AbCellera Biologics

4.69 USD
--0.18
3.7%
At close Updated Nov 5, 4:00 PM EST
Pre-market
After hours
4.77
+0.08
1.71%
1 day
-3.7%
5 days
-15.34%
1 month
-20.1%
3 months
7.57%
6 months
114.16%
Year to date
54.79%
1 year
72.43%
5 years
-92.04%
10 years
-92.04%
 

About: AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Employees: 596

0
Funds holding %
of 7,509 funds
0
Analysts bullish %
of 1 analysts
Positive news %
of articles
Price charts implemented using Lightweight Charts™